Market Segmentation:
- By Product Type
- Fixed Angio Suites
- Mobile Angio Suites
- Biplane Angio Suites
- Others (Floor-mounted, Ceiling-mounted)
- By Technology
- X-ray Angiography
- Computed Tomography (CT) Angiography
- Magnetic Resonance Angiography (MRA)
- Others (Positron Emission Tomography, Ultrasound)
- By Application
- Cardiac Angiography
- Neurology Angiography
- Oncology Angiography
- Peripheral Vascular Angiography
- Others (Pediatric, Obstetrics/Gynecology)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Others (Research Institutes, Academic & Teaching Hospitals)
- By Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Angio Suites industry is approximately USD 1.8 billion.
Increasing prevalence of cardiovascular diseases, Technological advancements in imaging modalities, Growing adoption of minimally invasive procedures, Rising healthcare expenditure, Aging population, Increasing focus on early disease diagnosis, Expansion of healthcare infrastructure in emerging markets, Favorable reimbursement policies, Growing medical tourism, Increasing investments in research and development.
High cost of angio suites, Shortage of skilled professionals, Strict regulatory guidelines, Risk of radiation exposure, Reimbursement challenges, Lack of awareness in underdeveloped regions, Healthcare infrastructure limitations in certain regions.
The leading component segment in the Angio Suites Market is the fixed angio suites segment, widely used for advanced imaging and interventional procedures.
The major players operating in the Angio Suites Market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., NeuroLogica Corp., Elekta AB, and Toshiba Medical Systems Corporation.
The North America region is expected to lead the Angio Suites Market, with a projected market size of USD 1.2 billion in 2024.
Increasing prevalence of cardiovascular diseases, Technological advancements, Growing adoption of minimally invasive procedures, Rising healthcare expenditure, Aging population, Expansion of healthcare infrastructure, Favorable reimbursement policies, Growing medical tourism.